Respirology Case Reports is a distinguished peer-reviewed journal published by WILEY, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2013, this Open Access journal has provided a platform for the publication of high-quality case reports that enhance our understanding of various respiratory conditions, fostering collaboration and knowledge dissemination among healthcare professionals, researchers, and students alike. With an impact factor that reflects its growing influence, Respirology Case Reports aims to illuminate rare and complex cases, thus contributing vital insights that enhance clinical practice. Located in the United Kingdom, this journal serves as an essential resource for advancing research and improving patient outcomes in respiratory health. Currently ranked in the Q3 quartile for Pulmonary and Respiratory Medicine, it showcases case studies that not only enrich academic discourse but also promote the application of evidence-based practices in real-world settings.

Case Reports in Neurology is a distinguished open-access journal published by KARGER, dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2009, the journal has provided a vital platform for the dissemination of clinical case reports, enhancing the understanding of various neurological disorders and their management. With an ISSN of 1662-680X, it is indexed in Scopus, ranking #295 out of 400 in the neurology (clinical) category for 2023, placing it in the 26th percentile. The journal welcomes contributions from researchers, clinicians, and students alike, offering insights into unique cases and treatment outcomes that can significantly impact clinical practice. Located in Basel, Switzerland, the journal emphasizes the importance of sharing exceptional clinical experiences that can inform future research and evidence-based practices. By promoting open access, Case Reports in Neurology ensures that valuable information is available to the global medical community, further bridging gaps in neurology research and clinical application.

Case Reports in Oncology is a peer-reviewed journal published by KARGER, dedicated to the dissemination of high-quality case studies and clinical reports in the field of oncology. Since its transition to Open Access in 2008, this Swiss-based journal has aimed to broaden the accessibility of key findings to a global audience of researchers, healthcare professionals, and students. The journal is positioned in the Q3 quartile for oncology, indicating its valuable contribution to the field, while also holding a Scopus rank of 294 out of 404 in Medicine, with a percentile of 27%. However, its open access model ensures that even those outside of traditional academic institutions can engage with critical advancements and novel insights from the oncology community. With a publication span extending from 2010 to 2024, Case Reports in Oncology serves as a crucial platform for sharing unique clinical experiences and innovative treatment strategies, ultimately enriching the practice and study of oncology.

AME Case Reports, published by AME PUBLISHING COMPANY, is a peer-reviewed open-access journal dedicated to the dissemination of high-quality clinical case reports across various medical disciplines. With an expanding focus on innovative medical practices and clinical experiences, this journal serves as an essential platform for healthcare professionals, researchers, and medical students to share significant findings and insights that contribute to evidence-based practices. Although specific metrics such as impact factors and H-index are not currently available, the journal's commitment to academic rigor and accessibility fosters an environment for scholarly exchange and professional development. The publication facilitates immediate access to important case studies that may inform clinical decisions and improve patient care. In an era where sharing specialized knowledge is paramount, AME Case Reports stands as a vital resource for those involved in the medical community worldwide.

Case Reports in Hematology, published by HINDAWI LTD, stands as a prominent open-access journal dedicated to disseminating innovative case reports that contribute significantly to the field of hematology. Established in 2011, this journal provides a vital platform for researchers, practitioners, and clinicians to share detailed observations and novel findings related to blood disorders and treatment responses. With its commitment to high-quality research and accessibility, Case Reports in Hematology aims to enhance the understanding of hematological conditions, fostering collaboration and dialogue among professionals in the discipline. By leveraging an open-access model, the journal ensures that its valuable content is readily available to a global audience, consequently promoting advanced research and improving patient care in hematology. As a testament to its academic rigor and relevance, the journal appeals to its readership, which includes researchers, healthcare professionals, and students eager to expand their knowledge and insights into this critical area of medicine.

Case Reports in Gastrointestinal Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of significant findings in the field of gastrointestinal medicine. Established in 2011, this journal champions the accessibility of scholarly work, allowing researchers, professionals, and students to explore vital case studies that enhance clinical understanding and patient care across various gastrointestinal conditions. With an emphasis on innovative practices and advances in treatment, the journal serves as an invaluable resource for those committed to furthering their knowledge and improving outcomes in gastrointestinal health. By promoting the robust sharing of case reports and clinical insights, Case Reports in Gastrointestinal Medicine not only contributes to the academic community but also supports practitioners in their quest for evidence-based practice.

AUTOIMMUNITY REVIEWS is an esteemed journal in the field of immunology and allergy, published by Elsevier and located in the Netherlands. With a remarkable impact reflected in its Q1 category rankings for both Immunology and Allergy, this journal stands at the forefront of advancing research and knowledge in autoimmune diseases. Its Scopus rankings are particularly notable, placing it at #14 in the Immunology and Allergy category and #17 in the broader scope of Immunology and Microbiology, underscoring its influential role in the scientific community with a commendable 94th percentiles in both domains. Since its inception in 2002, AUTOIMMUNITY REVIEWS has provided a multidisciplinary platform for researchers and practitioners to share landmark studies, case reports, and reviews that propel the understanding of autoimmune disorders. Although it does not currently operate under an open-access model, the journal ensures rigorous peer review and high-quality publications, making it an essential resource for anyone looking to stay informed about the latest developments in autoimmune research.

Case Reports in Dermatology is a leading Open Access academic journal dedicated to the publication of case reports and unique clinical findings in the field of dermatology. Published by KARGER and based in Switzerland, the journal has been an open access resource since 2009, enhancing the visibility and accessibility of vital research for dermatology professionals and the scientific community. With an impressive ISSN of 1662-6567 and ranking in the Q3 category among dermatological journals, it serves as a crucial platform for researchers seeking to share innovative case studies, validate diagnostic approaches, and explore treatment outcomes. The journal continues to contribute to advancing dermatological science with a convergence timeline extending from 2010 to 2024. By promoting the dissemination of emerging knowledge and practices, Case Reports in Dermatology plays a significant role in fostering collaboration among practitioners, enhancing educational efforts, and ultimately improving patient care in dermatology.

Therapeutic Advances in Allergy and Rhinology, published by SAGE Publications Inc, is an esteemed journal that focuses on advancing the fields of allergy and rhinology through innovative and impactful research. As an Open Access journal, it provides a platform for researchers, clinicians, and students to share significant findings and therapeutic developments aimed at improving patient outcomes related to allergic conditions and nasal disorders. The journal aims to publish high-quality peer-reviewed articles, reviews, and case studies that contribute to a deeper understanding of the pathophysiology and management of allergies and rhinological conditions. By fostering collaborative dialogue across various disciplines, Therapeutic Advances in Allergy and Rhinology plays a crucial role in enhancing clinical practice and guiding future research in this vital area of health. With an ISSN of 2753-4030, the journal continues to establish itself as a key resource for anyone involved in allergy and rhinology research and practice.

AIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.